Atherosclerosis

2016/02/18 by Peter Libby, Karin E. Bornfeldt, Karin Bornfeldt +1 · 25 citations
Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Lipoproteins and Cardiovascular Health #Diabetes, Cardiovascular Risks, and Lipoproteins

paper · pdf · doi:10.1161/circresaha.116.308334

Abstract

This new compendium of 16 articles "reviews the current state-of-the-art of atherosclerosis research spanning from a global health perspective to fundamental molecular mechanisms. The editors intend this collection of articles not only to celebrate the successes but also to highlight the emerging challenges to many tenets of belief that have emerged from recent studies. We do so in the spirit of inspiring future research to attack the unresolved questions and to exploit the newer discoveries that have opened unanticipated horizons of understanding and raised novel questions and opportunities for therapies."

Cited by

• Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. [europepmc]
• SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection. [europepmc]
• MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis. [europepmc]
• Impaired mitochondrial respiration in human carotid plaque atherosclerosis: A potential role for Pink1 in vascular smooth muscle cell energetics. [europepmc]
• Endothelial Cell Metabolism. [europepmc]
• Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article. [europepmc]
• Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis. [europepmc]
• Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based. [europepmc]
• Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis. [europepmc]
• Targeting Non-coding RNA in Vascular Biology and Disease. [europepmc]
• Coronary artery spasm - Clinical features, pathogenesis and treatment. [europepmc]
• Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. [europepmc]
• Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. [europepmc]
• Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. [europepmc]
• Novel Plaque Enriched Long Noncoding RNA in Atherosclerotic Macrophage Regulation (PELATON). [europepmc]
• Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice. [europepmc]
• Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity. [europepmc]
• Coronary Artery Spasm: New Insights. [europepmc]
• The Role of Mitochondria in Cardiovascular Diseases. [europepmc]
• Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications. [europepmc]
• Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches. [europepmc]
• Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway. [europepmc]
• Emerging Roles of Ceramide in Cardiovascular Diseases. [europepmc]
• Recent Progress in in vitro Models for Atherosclerosis Studies. [europepmc]
• Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development. [europepmc]

Related

• Atherosclerosis: Recent developments
• Atherosclerosis Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective
• Atherosclerosis: Making a U Turn
• Pathophysiology of Atherosclerosis
• The Role of Inflammation in Cardiovascular Disease